(Alliance News) - Datrix Spa announced Thursday that it has been awarded a major European call for proposals - Horizon Europe - in the area of AI for healthcare.

The research project is called "Better," an acronym for Better Real-World Health-Data Distributed Analytics Research Platform, and aims to create a user-friendly platform that physicians in European hospitals will be able to use to view patient data - comparable and filterable by pathology or genetic parameters - and train predictive models, while complying with the most stringent privacy regulations globally related to health information, all through a federated learning and distributed AI approach.

In total, this is EUR10 million in funds allocated at the European level, about half of which will be used for genetic sequencing, since the genetic component is essential in the diseases being analyzed, divided into three macro-areas and as many applications: rare pediatric diseases, autism spectrum disorders in children and adolescents, and congenital visual problems, with a focus on retinal diseases.

The project was officially approved in August this year and will begin Dec. 1.

"This is a great achievement for Datrix, which confirms the group's ability to be at the frontier of innovation, to attract significant financial resources from the European Commission, and to prove its leadership in innovation projects as coordinators of a prestigious consortium composed of international universities, research centers and clinical institutes," said Fabrizio Milano d'Aragona, Co-Founder and CEO of Datrix.

"In addition to accessing innovative technological assets and gaining expertise on frontier topics, the Better project will allow us to deepen our research, already underway, on federated learning, a new approach of the AI world, returning value to society. Federated data management overcomes the limitations dictated by privacy regulations, allowing us to pool information about patients and what the genetic component can tell to prevent, diagnose in time and treat many diseases, including serious ones."

Datrix's stock is up 1.7 percent at EUR1.83 per share.

By Giuseppe Fabio Ciccomascolo, Alliance News senior reporter

Comments and questions to redazione@alliancenews.com

Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.